Trials / Completed
CompletedNCT00910104
Cholestasis Reversal: Efficacy of IV Fish Oil
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Mark Puder · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Omegaven is effective in the treatment of parenteral nutrition associated liver disease (PNALD).
Detailed description
The purpose of this study is to determine whether the omega-3 fatty acid emulsion (Omegaven), when used in lieu of the conventional soy-based fat emulsion (Intralipid), is effective in the treatment of parenteral nutrition associated liver disease (PNALD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omegaven® | 10% Omegaven® 1g/kg/day, IV (in the vein) until the patient no longer requires parenteral nutrition or until participation in the study is terminated |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2019-01-23
- Completion
- 2019-01-23
- First posted
- 2009-05-29
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00910104. Inclusion in this directory is not an endorsement.